UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
-
SDG 2 Zero Hunger -
SDG 3 Good Health and Well-being -
SDG 7 Affordable and Clean Energy -
SDG 11 Sustainable Cities and Communities -
SDG 13 Climate Action -
SDG 14 Life Below Water -
SDG 15 Life on Land -
SDG 16 Peace, Justice and Strong Institutions
Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
Samuel Awuah, Ph.D.
- Chemistry - Associate Professor
- Pharmaceutical Sciences - Joint Appointment
- Center for Computational Sciences - Member
- Markey Cancer Center / Cancer Research Priority Initiative - TO Program Leader, Member
- Translational Oncology Research Program - Member
Person
-
Younsoo Bae, Ph.D.
- Pharmaceutical Sciences - Associate Professor
- Markey Cancer Center / Cancer Research Priority Initiative - Member
- Materials Science Research Priority Initiative
- Translational Oncology Research Program - Member
Person
-
Bjoern Bauer, Ph.D.
- Pharmaceutical Sciences - Professor, Patrick P. DeLuca Pharmaceutical Tecnology Professorship in the College of Pharmacy
- Markey Cancer Center / Cancer Research Priority Initiative - Member
- Neuroscience Research Priority Area
- Translational Oncology Research Program - Member
Person
-
Novel Antibiotic Alternatives for the Treatment of Subclinical Rhodococcus Equi Pneumonia in Foals
Helmy, Y. A. (PI), Mahmoud, K. A. (CoI) & Thorson, J. (CoI)
4/1/26 → 3/31/28
Project: Research project
-
Targeting Intracellular Cholesterol Distribution: Mechanisms and Therapeutic Strategies for Metabolic dysfunction-associated steatotic liver disease (MASLD)
Prisinzano, T. (PI), Czuba, L. (CoI) & Xiao, X. (CoI)
National Institute Diabetes & Digestive & Kidney
3/12/26 → 2/28/31
Project: Research project
-
Targeting Intracellular Cholesterol Distribution: Mechanisms and Therapeutic Strategies for Metabolic dysfunction-associated steatotic liver disease (MASLD)
Xiao, X. (PI), Czuba, L. (CoI), Graf, G. (CoI), Johnson, L. (CoI), Prisinzano, T. (CoI) & Shelman, N. (CoI)
National Institute Diabetes & Digestive & Kidney
3/12/26 → 2/28/31
Project: Research project
Research output
-
Being treated as the expert: A blueprint for a community advisory board approach to elevate the voice of people with living experience with substance use in academic research
Moffitt, T., Henson, B., Young, A., Walsh, S. L., Vickers-Smith, R., Cruz, J., Byard, J., West, B. & Fallin-Bennett, A., Feb 5 2026, In: Journal of Clinical and Translational Science. 10, 1, e74.Research output: Contribution to journal › Article › peer-review
Open Access -
Buprenorphine utilization following removal of prior authorization requirements in the Kentucky Medicaid population
Miracle, D. K., Hammerslag, L. R., Slavova, S., Lofwall, M. R., Walsh, S. L., Talbert, J. & Freeman, P. R., May 1 2026, In: Drug and Alcohol Dependence. 282, 113105.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical and demographic characteristics of participants in a hepatitis C treatment trial in rural Kentucky: How policies around treatment access may impact elimination efforts in the United States
Havens, J. R., Williams, B. D., Schaninger, T., Shepherd-Tackett, V. A., Lofwall, M. R., Staton, M., Walsh, S. L. & Knudsen, H. K., Jan 1 2026, In: Journal of Rural Health. 42, 1, e70128.Research output: Contribution to journal › Article › peer-review
Open Access
Prizes
Activities
- 1 Editorial work
-
Journal of Medicinal Chemistry (Journal)
Guy, R. K. (Reviewer)
2014 → …Activity: Publication peer-review and editorial work › Editorial work